Bayer today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for expanded capabilities of its MEDRAD ® MRXperion Magnetic Resonance (MR) Injection System, a power ...
The FDA's expanded clearances broaden the application of Bayer's Medrad MRXperion system across a wider range of MR settings.
Bayer recently received FDA approval for a connected auto-injector for relapsing-remitting multiple sclerosis medication and companion app. The device is called the Betaconnect Electronic Autoinjector ...
CHICAGO--(BUSINESS WIRE)--Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline as well as innovations around Artificial Intelligence (AI) and will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results